10.24335/L20092
RoyaltyStat
Amendment to exclusive patent, technology and know-how license to develop, make, have made, use and sell pharmaceutical and radiopharmaceutical compositions and immunoassay products incorporating CDK-D development compounds, and radiopharmaceutical compositions and immunoassay products incorporating UBC development compounds, excluding antisense, gene therapy and non-radiopharmaceutical diagnostic applications; and exclusive patent, know-how and copyright crosslicense to discover, develop, make, have made, use, and sell antisense and gene therapy products in the oncology field incorporating a compound that was developed using CDK targets within 4 years following termination of the research program.
RoyaltyStat
1997